Frequency Therapeutics Alpha and Beta Analysis
| FREQDelisted Stock | USD 0.52 0.03 5.45% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Frequency Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Frequency Therapeutics over a specified time horizon. Remember, high Frequency Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Frequency Therapeutics' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Frequency |
Frequency Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Frequency Therapeutics market risk premium is the additional return an investor will receive from holding Frequency Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Frequency Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Frequency Therapeutics' performance over market.| α | 0.00 | β | 0.00 |
Frequency Therapeutics Fundamentals Vs Peers
Comparing Frequency Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Frequency Therapeutics' direct or indirect competition across all of the common fundamentals between Frequency Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Frequency Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Frequency Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Frequency Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Frequency Therapeutics to competition |
| Fundamentals | Frequency Therapeutics | Peer Average |
| Return On Equity | -1.0 | -0.31 |
| Return On Asset | -0.42 | -0.14 |
| Current Valuation | 512.86 M | 16.62 B |
| Shares Outstanding | 36.52 M | 571.82 M |
| Shares Owned By Insiders | 7.26 % | 10.09 % |
| Shares Owned By Institutions | 14.12 % | 39.21 % |
| Number Of Shares Shorted | 365.89 K | 4.71 M |
Frequency Therapeutics Opportunities
Frequency Therapeutics Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Frequency Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Frequency or other delisted stocks. Alpha measures the amount that position in Frequency Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Frequency Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Frequency Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Frequency Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Frequency Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Frequency Therapeutics. Please utilize our Beneish M Score to check the likelihood of Frequency Therapeutics' management manipulating its earnings.
| 14th of November 2023 Upcoming Quarterly Report | View | |
| 8th of March 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 8th of March 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Frequency Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |